血管同種移植の世界市場2023年:皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片

■ 英語タイトル:Global Vascular Allografts Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA8486)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA8486
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:87
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血管同種移植の世界市場2023年:皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

本調査資料は血管同種移植のグローバル市場について調査・分析し、世界の血管同種移植市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析(皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片)、用途別セグメント分析(病院、クリニック、その他)、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Medtronic、CryoLife、LeMaitre、LifeNet Health、DePuy Synthes、Anika Therapeutics、Stryker、NuVasive、Bioventusなどが含まれています。血管同種移植のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、血管同種移植市場規模を算出する際に考慮しました。

・血管同種移植市場の概要
- 製品の定義
- 血管同種移植の種類別セグメント
- 世界の血管同種移植市場規模:タイプ別分析(皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片)
- 血管同種移植の用途別セグメント
- 世界の血管同種移植市場規模:用途別分析(病院、クリニック、その他)
- 世界の血管同種移植市場規模予測(2018年-2029年)
- 血管同種移植の平均価格推移(2018年-2029年)
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 血管同種移植市場の競争状況およびトレンド

・血管同種移植の地域別市場規模
- 北米の血管同種移植市場規模(2018年-2029年)
- 米国の血管同種移植市場規模(2018年-2029年)
- ヨーロッパの血管同種移植市場規模(2018年-2029年)
- アジア太平洋の血管同種移植市場規模(2018年-2029年)
- 中国の血管同種移植市場規模(2018年-2029年)
- 日本の血管同種移植市場規模(2018年-2029年)
- 韓国の血管同種移植市場規模(2018年-2029年)
- インドの血管同種移植市場規模(2018年-2029年)
- オーストラリアの血管同種移植市場規模(2018年-2029年)
- 中南米の血管同種移植市場規模(2018年-2029年)
- 中東・アフリカの血管同種移植市場規模(2018年-2029年)

・種類別セグメント:皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片
- 世界の血管同種移植のタイプ別販売量(2018年-2023年)
- 世界の血管同種移植のタイプ別売上(2018年-2023年)
- 世界の血管同種移植のタイプ別価格

・用途別セグメント:病院、クリニック、その他
- 世界の血管同種移植の用途別販売量(2018年-2023年)
- 世界の血管同種移植の用途別売上(2018年-2023年)
- 世界の血管同種移植の用途別価格

・主要企業のプロファイル:企業情報、事業概要、売上、製品ポートフォリオ、動向
Medtronic、CryoLife、LeMaitre、LifeNet Health、DePuy Synthes、Anika Therapeutics、Stryker、NuVasive、Bioventus

・産業チェーンと販売チャネルの分析
- 血管同種移植産業チェーン分析
- 血管同種移植の主要原材料
- 血管同種移植の販売チャネル
- 血管同種移植のディストリビューター
- 血管同種移植の主要顧客

・血管同種移植市場ダイナミクス
- 血管同種移植の業界動向
- 血管同種移植市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Vascular Allografts market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Vascular Allografts is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Vascular Allografts is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Vascular Allografts include Medtronic, CryoLife, LeMaitre, LifeNet Health, DePuy Synthes, Anika Therapeutics, Stryker, NuVasive and Bioventus, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vascular Allografts, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vascular Allografts.
The Vascular Allografts market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vascular Allografts market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vascular Allografts manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Medtronic
CryoLife
LeMaitre
LifeNet Health
DePuy Synthes
Anika Therapeutics
Stryker
NuVasive
Bioventus
Segment by Type
Cortical Allograft
Cancellous Allograft
Corticocancellous Allograft
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vascular Allografts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vascular Allografts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Vascular Allografts Market Overview
1.1 Product Overview and Scope of Vascular Allografts
1.2 Vascular Allografts Segment by Type
1.2.1 Global Vascular Allografts Market Value Comparison by Type (2023-2029)
1.2.2 Cortical Allograft
1.2.3 Cancellous Allograft
1.2.4 Corticocancellous Allograft
1.3 Vascular Allografts Segment by Application
1.3.1 Global Vascular Allografts Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Vascular Allografts Market Size Estimates and Forecasts
1.4.1 Global Vascular Allografts Revenue 2018-2029
1.4.2 Global Vascular Allografts Sales 2018-2029
1.4.3 Global Vascular Allografts Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vascular Allografts Market Competition by Manufacturers
2.1 Global Vascular Allografts Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vascular Allografts Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vascular Allografts Average Price by Manufacturers (2018-2023)
2.4 Global Vascular Allografts Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vascular Allografts, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vascular Allografts, Product Type & Application
2.7 Vascular Allografts Market Competitive Situation and Trends
2.7.1 Vascular Allografts Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vascular Allografts Players Market Share by Revenue
2.7.3 Global Vascular Allografts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vascular Allografts Retrospective Market Scenario by Region
3.1 Global Vascular Allografts Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vascular Allografts Global Vascular Allografts Sales by Region: 2018-2029
3.2.1 Global Vascular Allografts Sales by Region: 2018-2023
3.2.2 Global Vascular Allografts Sales by Region: 2024-2029
3.3 Global Vascular Allografts Global Vascular Allografts Revenue by Region: 2018-2029
3.3.1 Global Vascular Allografts Revenue by Region: 2018-2023
3.3.2 Global Vascular Allografts Revenue by Region: 2024-2029
3.4 North America Vascular Allografts Market Facts & Figures by Country
3.4.1 North America Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vascular Allografts Sales by Country (2018-2029)
3.4.3 North America Vascular Allografts Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vascular Allografts Market Facts & Figures by Country
3.5.1 Europe Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vascular Allografts Sales by Country (2018-2029)
3.5.3 Europe Vascular Allografts Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vascular Allografts Market Facts & Figures by Country
3.6.1 Asia Pacific Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vascular Allografts Sales by Country (2018-2029)
3.6.3 Asia Pacific Vascular Allografts Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vascular Allografts Market Facts & Figures by Country
3.7.1 Latin America Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vascular Allografts Sales by Country (2018-2029)
3.7.3 Latin America Vascular Allografts Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vascular Allografts Market Facts & Figures by Country
3.8.1 Middle East and Africa Vascular Allografts Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vascular Allografts Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vascular Allografts Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vascular Allografts Sales by Type (2018-2029)
4.1.1 Global Vascular Allografts Sales by Type (2018-2023)
4.1.2 Global Vascular Allografts Sales by Type (2024-2029)
4.1.3 Global Vascular Allografts Sales Market Share by Type (2018-2029)
4.2 Global Vascular Allografts Revenue by Type (2018-2029)
4.2.1 Global Vascular Allografts Revenue by Type (2018-2023)
4.2.2 Global Vascular Allografts Revenue by Type (2024-2029)
4.2.3 Global Vascular Allografts Revenue Market Share by Type (2018-2029)
4.3 Global Vascular Allografts Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vascular Allografts Sales by Application (2018-2029)
5.1.1 Global Vascular Allografts Sales by Application (2018-2023)
5.1.2 Global Vascular Allografts Sales by Application (2024-2029)
5.1.3 Global Vascular Allografts Sales Market Share by Application (2018-2029)
5.2 Global Vascular Allografts Revenue by Application (2018-2029)
5.2.1 Global Vascular Allografts Revenue by Application (2018-2023)
5.2.2 Global Vascular Allografts Revenue by Application (2024-2029)
5.2.3 Global Vascular Allografts Revenue Market Share by Application (2018-2029)
5.3 Global Vascular Allografts Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Vascular Allografts Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 CryoLife
6.2.1 CryoLife Corporation Information
6.2.2 CryoLife Description and Business Overview
6.2.3 CryoLife Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CryoLife Vascular Allografts Product Portfolio
6.2.5 CryoLife Recent Developments/Updates
6.3 LeMaitre
6.3.1 LeMaitre Corporation Information
6.3.2 LeMaitre Description and Business Overview
6.3.3 LeMaitre Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LeMaitre Vascular Allografts Product Portfolio
6.3.5 LeMaitre Recent Developments/Updates
6.4 LifeNet Health
6.4.1 LifeNet Health Corporation Information
6.4.2 LifeNet Health Description and Business Overview
6.4.3 LifeNet Health Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LifeNet Health Vascular Allografts Product Portfolio
6.4.5 LifeNet Health Recent Developments/Updates
6.5 DePuy Synthes
6.5.1 DePuy Synthes Corporation Information
6.5.2 DePuy Synthes Description and Business Overview
6.5.3 DePuy Synthes Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DePuy Synthes Vascular Allografts Product Portfolio
6.5.5 DePuy Synthes Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Anika Therapeutics Vascular Allografts Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Stryker
6.6.1 Stryker Corporation Information
6.6.2 Stryker Description and Business Overview
6.6.3 Stryker Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Stryker Vascular Allografts Product Portfolio
6.7.5 Stryker Recent Developments/Updates
6.8 NuVasive
6.8.1 NuVasive Corporation Information
6.8.2 NuVasive Description and Business Overview
6.8.3 NuVasive Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.8.4 NuVasive Vascular Allografts Product Portfolio
6.8.5 NuVasive Recent Developments/Updates
6.9 Bioventus
6.9.1 Bioventus Corporation Information
6.9.2 Bioventus Description and Business Overview
6.9.3 Bioventus Vascular Allografts Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bioventus Vascular Allografts Product Portfolio
6.9.5 Bioventus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vascular Allografts Industry Chain Analysis
7.2 Vascular Allografts Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vascular Allografts Production Mode & Process
7.4 Vascular Allografts Sales and Marketing
7.4.1 Vascular Allografts Sales Channels
7.4.2 Vascular Allografts Distributors
7.5 Vascular Allografts Customers
8 Vascular Allografts Market Dynamics
8.1 Vascular Allografts Industry Trends
8.2 Vascular Allografts Market Drivers
8.3 Vascular Allografts Market Challenges
8.4 Vascular Allografts Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Vascular Allografts Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Vascular Allografts Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Vascular Allografts Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vascular Allografts Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Vascular Allografts Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Vascular Allografts Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Vascular Allografts Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Vascular Allografts Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Vascular Allografts, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Vascular Allografts, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vascular Allografts, Product Type & Application
Table 12. Global Key Manufacturers of Vascular Allografts, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vascular Allografts by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vascular Allografts as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vascular Allografts Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vascular Allografts Sales by Region (2018-2023) & (K Units)
Table 18. Global Vascular Allografts Sales Market Share by Region (2018-2023)
Table 19. Global Vascular Allografts Sales by Region (2024-2029) & (K Units)
Table 20. Global Vascular Allografts Sales Market Share by Region (2024-2029)
Table 21. Global Vascular Allografts Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Vascular Allografts Revenue Market Share by Region (2018-2023)
Table 23. Global Vascular Allografts Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vascular Allografts Revenue Market Share by Region (2024-2029)
Table 25. North America Vascular Allografts Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vascular Allografts Sales by Country (2018-2023) & (K Units)
Table 27. North America Vascular Allografts Sales by Country (2024-2029) & (K Units)
Table 28. North America Vascular Allografts Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Vascular Allografts Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vascular Allografts Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vascular Allografts Sales by Country (2018-2023) & (K Units)
Table 32. Europe Vascular Allografts Sales by Country (2024-2029) & (K Units)
Table 33. Europe Vascular Allografts Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Vascular Allografts Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vascular Allografts Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vascular Allografts Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Vascular Allografts Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Vascular Allografts Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Vascular Allografts Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vascular Allografts Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vascular Allografts Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Vascular Allografts Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Vascular Allografts Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vascular Allografts Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vascular Allografts Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vascular Allografts Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Vascular Allografts Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Vascular Allografts Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Vascular Allografts Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vascular Allografts Sales (K Units) by Type (2018-2023)
Table 51. Global Vascular Allografts Sales (K Units) by Type (2024-2029)
Table 52. Global Vascular Allografts Sales Market Share by Type (2018-2023)
Table 53. Global Vascular Allografts Sales Market Share by Type (2024-2029)
Table 54. Global Vascular Allografts Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Vascular Allografts Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vascular Allografts Revenue Market Share by Type (2018-2023)
Table 57. Global Vascular Allografts Revenue Market Share by Type (2024-2029)
Table 58. Global Vascular Allografts Price (US$/Unit) by Type (2018-2023)
Table 59. Global Vascular Allografts Price (US$/Unit) by Type (2024-2029)
Table 60. Global Vascular Allografts Sales (K Units) by Application (2018-2023)
Table 61. Global Vascular Allografts Sales (K Units) by Application (2024-2029)
Table 62. Global Vascular Allografts Sales Market Share by Application (2018-2023)
Table 63. Global Vascular Allografts Sales Market Share by Application (2024-2029)
Table 64. Global Vascular Allografts Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Vascular Allografts Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vascular Allografts Revenue Market Share by Application (2018-2023)
Table 67. Global Vascular Allografts Revenue Market Share by Application (2024-2029)
Table 68. Global Vascular Allografts Price (US$/Unit) by Application (2018-2023)
Table 69. Global Vascular Allografts Price (US$/Unit) by Application (2024-2029)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Medtronic Vascular Allografts Product
Table 74. Medtronic Recent Developments/Updates
Table 75. CryoLife Corporation Information
Table 76. CryoLife Description and Business Overview
Table 77. CryoLife Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CryoLife Vascular Allografts Product
Table 79. CryoLife Recent Developments/Updates
Table 80. LeMaitre Corporation Information
Table 81. LeMaitre Description and Business Overview
Table 82. LeMaitre Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. LeMaitre Vascular Allografts Product
Table 84. LeMaitre Recent Developments/Updates
Table 85. LifeNet Health Corporation Information
Table 86. LifeNet Health Description and Business Overview
Table 87. LifeNet Health Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. LifeNet Health Vascular Allografts Product
Table 89. LifeNet Health Recent Developments/Updates
Table 90. DePuy Synthes Corporation Information
Table 91. DePuy Synthes Description and Business Overview
Table 92. DePuy Synthes Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. DePuy Synthes Vascular Allografts Product
Table 94. DePuy Synthes Recent Developments/Updates
Table 95. Anika Therapeutics Corporation Information
Table 96. Anika Therapeutics Description and Business Overview
Table 97. Anika Therapeutics Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Anika Therapeutics Vascular Allografts Product
Table 99. Anika Therapeutics Recent Developments/Updates
Table 100. Stryker Corporation Information
Table 101. Stryker Description and Business Overview
Table 102. Stryker Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Stryker Vascular Allografts Product
Table 104. Stryker Recent Developments/Updates
Table 105. NuVasive Corporation Information
Table 106. NuVasive Description and Business Overview
Table 107. NuVasive Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. NuVasive Vascular Allografts Product
Table 109. NuVasive Recent Developments/Updates
Table 110. Bioventus Corporation Information
Table 111. Bioventus Description and Business Overview
Table 112. Bioventus Vascular Allografts Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Bioventus Vascular Allografts Product
Table 114. Bioventus Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Vascular Allografts Distributors List
Table 118. Vascular Allografts Customers List
Table 119. Vascular Allografts Market Trends
Table 120. Vascular Allografts Market Drivers
Table 121. Vascular Allografts Market Challenges
Table 122. Vascular Allografts Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vascular Allografts
Figure 2. Global Vascular Allografts Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Vascular Allografts Market Share by Type in 2022 & 2029
Figure 4. Cortical Allograft Product Picture
Figure 5. Cancellous Allograft Product Picture
Figure 6. Corticocancellous Allograft Product Picture
Figure 7. Global Vascular Allografts Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Vascular Allografts Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Vascular Allografts Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Vascular Allografts Market Size (2018-2029) & (US$ Million)
Figure 14. Global Vascular Allografts Sales (2018-2029) & (K Units)
Figure 15. Global Vascular Allografts Average Price (US$/Unit) & (2018-2029)
Figure 16. Vascular Allografts Report Years Considered
Figure 17. Vascular Allografts Sales Share by Manufacturers in 2022
Figure 18. Global Vascular Allografts Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Vascular Allografts Players: Market Share by Revenue in 2022
Figure 20. Vascular Allografts Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Vascular Allografts Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Vascular Allografts Sales Market Share by Country (2018-2029)
Figure 23. North America Vascular Allografts Revenue Market Share by Country (2018-2029)
Figure 24. United States Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Vascular Allografts Sales Market Share by Country (2018-2029)
Figure 27. Europe Vascular Allografts Revenue Market Share by Country (2018-2029)
Figure 28. Germany Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Vascular Allografts Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Vascular Allografts Revenue Market Share by Region (2018-2029)
Figure 35. China Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Vascular Allografts Sales Market Share by Country (2018-2029)
Figure 45. Latin America Vascular Allografts Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Vascular Allografts Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Vascular Allografts Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Vascular Allografts Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Vascular Allografts by Type (2018-2029)
Figure 55. Global Revenue Market Share of Vascular Allografts by Type (2018-2029)
Figure 56. Global Vascular Allografts Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Vascular Allografts by Application (2018-2029)
Figure 58. Global Revenue Market Share of Vascular Allografts by Application (2018-2029)
Figure 59. Global Vascular Allografts Price (US$/Unit) by Application (2018-2029)
Figure 60. Vascular Allografts Value Chain
Figure 61. Vascular Allografts Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA8486 )"血管同種移植の世界市場2023年:皮質同種移植片、海綿状同種移植片、皮質海綿状同種移植片" (英文:Global Vascular Allografts Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。